Back to Search
Start Over
[Gaucher disease in childhood].
- Source :
-
La Revue de medecine interne [Rev Med Interne] 2007 Oct; Vol. 28 Suppl 2, pp. S183-6. - Publication Year :
- 2007
-
Abstract
- Gaucher disease is well-known in adult patients and must be regarded as a pediatric disease, two thirds of the patients manifesting before the age of 20. Three clinical forms have been defined based on the presence of neurological involvement. Gaucher disease type 1, without neurological signs, generally begins before the five years age with splenomegaly as the main symptom. The bone crises are more frequent than in adulthood. Gaucher disease type 2 or acute neuronopathic form begins between three and six months and do not have any treatment. Type 3 or chronic neuronopathic form appears like a type 1 with progressive horizontal saccade-initiation failure and developmental delay. Onset in childhood is predictive of a severe and progressive phenotype. The presence of neurological symptoms induces important consequences for treatment, prognosis and genetic counselling.
- Subjects :
- Adolescent
Adult
Age Factors
Analgesics therapeutic use
Child
Child, Preschool
Diphosphonates therapeutic use
Disease Progression
Electroencephalography
Genetic Counseling
Glucosylceramidase administration & dosage
Glucosylceramidase therapeutic use
Humans
Incidence
Infant
Infant, Newborn
Phenotype
Prognosis
Splenomegaly etiology
Time Factors
Gaucher Disease classification
Gaucher Disease diagnosis
Gaucher Disease epidemiology
Gaucher Disease genetics
Gaucher Disease therapy
Subjects
Details
- Language :
- French
- ISSN :
- 0248-8663
- Volume :
- 28 Suppl 2
- Database :
- MEDLINE
- Journal :
- La Revue de medecine interne
- Publication Type :
- Academic Journal
- Accession number :
- 18228686
- Full Text :
- https://doi.org/10.1016/s0248-8663(07)78879-3